Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a licensed medical professional before pursuing any treatment.
The best erectile dysfunction treatments in 2026 are not the same list they were five years ago. Texas men now have more targeted options than any previous generation, including FDA-approved oral medications, shockwave therapy, PRP injections like the P-Shot, and newer approaches like GlansGirth at InjectCo that go beyond ED support into overall penile health.
The challenge is not a lack of options. It is knowing which option fits your situation. This guide covers the full treatment landscape for 2026, breaks down what the clinical evidence actually shows, and explains how Texas men come to InjectCo’s nurse-led team to get real results without surgery or long-term pharmaceutical dependence. Let’s dive in.
ED is not rare and it is not just an older man’s issue. The global prevalence has been projected to approach 322 million cases, and that number keeps climbing. In clinical settings, providers are seeing more men in their 30s and 40s asking about treatment than ever before.
The causes are layered: vascular insufficiency, hormonal imbalance, nerve damage, metabolic conditions like diabetes, and psychological stress all contribute. That complexity is exactly why no single treatment works for every man, and why the most effective approach in 2026 combines diagnosis with personalized treatment selection.
A 2013 study found roughly one in four men under 40 reported difficulty achieving or maintaining erections. The drivers in younger populations tend to be lifestyle-related, such as disrupted sleep, chronic stress, sedentary habits, and rising rates of metabolic dysfunction. These men often respond especially well to regenerative treatments that address root causes rather than just triggering a short-term response.
Oral PDE5 inhibitors may work for a significant portion of men with mild to moderate ED, but they have real limitations. For men with venous leak, nerve damage, or significant vascular disease, pills often underdeliver. And even when they work, the effect ends when the drug clears the system. The clinical direction in 2026 is toward combination protocols and regenerative options that build toward lasting improvement.
| Treatment | Acts Quickly | Long-Term Benefit | Evidence Level | Best Suited For |
|---|---|---|---|---|
| Oral medications (Viagra, Cialis) | Yes | No | High | Mild to moderate ED, short-term |
| Shockwave therapy (Li-ESWT) | Slow onset | Moderate | Moderate | Vasculogenic ED |
| P-Shot (PRP) | Gradual | Moderate-High | Emerging | Blood flow support, non-drug option |
| GlansGirth (penile filler) | Gradual | Yes | Clinical | Girth + sensitivity + function |
| P-Long Protocol | Gradual | Yes | Emerging | Enhancement + function goals |
| Penile implants | Yes | Yes | High | Severe, treatment-resistant ED |
Not all treatments carry the same level of proof. In men’s health specifically, marketing moves faster than clinical data, so knowing where a treatment sits on the evidence spectrum matters.
Choosing an FDA-approved treatment does not automatically mean it is the best fit, and choosing an emerging therapy does not mean it is risky. Understanding the distinction helps you ask better questions.
PDE5 inhibitors remain the most commonly prescribed first-line option for ED. They work by relaxing smooth muscle and widening blood vessels to increase blood flow to the penis.
Sildenafil (Viagra) is taken on demand, typically 30 to 60 minutes before sexual activity. Tadalafil (Cialis) lasts up to 36 hours and is also available as a low daily dose. Both are well-tolerated by most men with mild to moderate vasculogenic ED.
Their main limitation, however, is that they manage symptoms, not causes. Once the drug clears your system, so does the effect. Men with nerve damage, severe vascular disease, or venous leak often find these drugs provide minimal benefit. Side effects, including headaches, flushing, and blood pressure drops with certain heart medications, are also worth discussing with a trusted provider before starting.
Low-intensity extracorporeal shockwave therapy (Li-ESWT) applies acoustic waves to penile tissue to stimulate new blood vessel formation and improve circulation over time. It is non-invasive, medication-free, and has a favorable safety profile.
A 2025 meta-analysis of 12 randomized controlled trials involving 882 men found statistically significant improvements in erectile function scores and erection hardness scores following Li-ESWT compared to sham treatment. A Cochrane review noted the effect may be modest but is consistent, particularly in men with mild to moderate vasculogenic ED.
Shockwave therapy works best as part of a broader plan. It is not a quick fix and typically requires multiple sessions over several weeks. For men who want a drug-free option and can commit to the protocol, it is worth having a serious conversation with a men’s health provider.
The P-Shot (Priapus Shot) uses platelet-rich plasma drawn from your own blood. After centrifuge separation, the concentrated PRP is injected into targeted areas of the penis. Natural growth factors in PRP support tissue repair, promote new blood vessel formation, and may improve nerve function over time.
A 2024 meta-analysis reviewing 12 controlled trials and 991 patients found PRP produced significantly better outcomes in erectile function scores compared to control groups, with a standardized mean difference of 0.59. A separate meta-analysis found significant improvements at one, three, and six months post-treatment with only mild adverse events and no serious adverse events reported.
The P-Shot tends to work best in men with mild to moderate vasculogenic ED who want a non-pharmaceutical option with the potential for lasting benefit. It is an emerging treatment, which means it is clinically promising and growing in the research base, but not yet first-line standard of care.
You can review how the P-Shot compares to shockwave therapy at injectco.com/p-shot-vs-shockwave/. For full procedure details, candidacy information, and what to expect, visit injectco.com/services/p-shot-dallas-fort-worth/.
GlansGirth is InjectCo’s proprietary approach to penile girth enhancement using hyaluronic acid filler. It is not a traditional ED treatment, but for many Texas men it addresses a closely related set of concerns, including reduced sensitivity, confidence during intimacy, and the performance anxiety that can compound erectile difficulties.
The procedure involves carefully placed filler to enhance girth and improve sensation in the glans and shaft. Results are gradual and have shown durability in InjectCo’s clinical experience across Texas. Unlike surgical enhancement, there is no general anesthesia, extended recovery or downtime, and permanent structural alteration required for this treatment.
This matters for ED patients because performance anxiety is one of the most common drivers of psychogenic ED in men under 50. When men feel better about their anatomy, clinical observation consistently shows improvement in confidence, arousal response, and reported erectile quality. GlansGirth does not replace medical ED treatment, but it is a meaningful adjunct for men whose challenges have a psychological or confidence component.
InjectCo offers GlansGirth across all Texas locations. For men who want to explore both P-Shot and GlansGirth together, a combined consultation is available. Visit injectco.com/services/penile-girth-enhancement/ for details.
The P-Long Protocol is a structured six-month program combining monthly PRP injections, a vacuum erection device (VED), and supplementation. It was designed with a dual focus: measurable size gains alongside sustained erectile function improvement.
A pilot study published in The Journal of Sexual Medicine found the protocol potentially improved erect penile length by 0.81 inches and girth by 0.47 inches over six months. All 29 participants subjectively reported better erectile function after completing the protocol. Results are expected to be long-lasting in a way that temporary solutions are not.
The P-Long Protocol requires a higher level of commitment than a single-session P-Shot. Monthly injections, consistent VED use between sessions, and adherence to the supplement protocol are all part of achieving the results. For men who are motivated and want both functional improvement and measurable enhancement, it is worth a detailed conversation with InjectCo’s licensed nurse providers.
Men researching ED options frequently look for evidence-backed supplement options alongside or instead of pharmaceuticals. Here is what the research actually shows for the most studied options.
L-Citrulline converts to L-arginine in the body, increasing nitric oxide production and improving blood flow. A small randomized trial found meaningful improvements in erection hardness scores compared to placebo. It is generally well tolerated and available over the counter. It is not a substitute for PDE5 inhibitors in moderate to severe ED, but as a lifestyle adjunct in mild cases it has the most consistent evidence.
Pycnogenol has shown synergistic benefit when combined with L-arginine or L-citrulline in several small trials. Proposed mechanism: enhanced nitric oxide synthesis. Evidence is promising but limited to small studies; it should not be marketed as a standalone ED treatment.
Several systematic reviews have found Panax ginseng produces modest but statistically significant improvement in ED scores compared to placebo. The effect size is smaller than PDE5 inhibitors. Best considered as a supportive option rather than primary treatment.
The FDA has issued warnings about numerous supplement products marketed for ED that contain hidden pharmaceutical ingredients, including sildenafil analogs. Men should purchase only from reputable sources and disclose all supplements to their provider.
Venous leak is one of the most underdiagnosed causes of ED treatment failure. Men try medication after medication without improvement and assume they are treatment-resistant. Often, the real issue is venous leak, a structural problem where blood exits the corpora cavernosa too quickly to sustain an erection.
The most common sign is difficulty maintaining an erection despite achieving initial arousal. Position changes during intercourse often cause rapid loss of erection. Oral medications may produce only partial or brief effects, if any.
Penile Doppler ultrasound is the standard diagnostic tool for venous leak. If you have had multiple treatment failures, ask your provider specifically about Doppler assessment before trying additional options.
If you’ve tried multiple treatments without improvement, venous leak evaluation is a critical next step before spending more on options that will not address the underlying problem.
| Severity | Presentation | Recommended Path |
|---|---|---|
| Mild | Occasional difficulty, largely functional | Lifestyle changes, PDE5 on demand, Li-ESWT as non-drug option |
| Moderate | Consistent difficulty getting or keeping erection | PDE5 + shockwave combination, P-Shot for vascular support, GlansGirth for confidence component |
| Severe / Treatment-Resistant | Multiple treatment failures, possible nerve/vascular damage | Penile implants (gold standard), venous embolization for confirmed venous leak, urologist referral |
| Psychogenic / Younger Men | Function intact but performance anxiety-driven | GlansGirth, P-Shot, counseling, lifestyle — avoid long-term pharmaceutical dependence early |
| Treatment | Estimated Cost (2026) | Insurance Coverage |
|---|---|---|
| Oral medications (generic) | $10 to $80 per dose | Widely covered by insurance for ED diagnosis |
| Shockwave therapy (full course) | $1,500 to $3,000+ | Not covered by most plans |
| P-Shot at InjectCo | $1,799 per session ($1,399 for new clients) | Not covered; CareCredit and Cherry financing available |
| GlansGirth at InjectCo | Pricing varies by volume | Not covered; financing available |
| P-Long Protocol (6 months) | $3,000 to $6,000+ | Not covered; CareCredit and Cherry financing available |
| Penile implants | $20,000 to $30,000+ | Insurance may cover portion for documented medical ED |
Who performs the P-Shot and GlansGirth matters as much as the procedure itself. Growth factor concentration, PRP preparation technique, injection placement, and clinical oversight all affect outcomes.
At InjectCo, every P-Shot and GlansGirth treatment is performed by licensed nurse injectors under physician oversight. No delegated injections, no shortcuts. InjectCo has treated more than 50,000 patients across Texas and maintains a five-star reputation across all locations. PRP preparation uses an FDA-cleared centrifuge system, and every patient receives a thorough consultation before any procedure.
InjectCo offers P-Shot and GlansGirth treatments in Dallas, Fort Worth, Plano, Colleyville, Argyle, The Woodlands, Waxahachie, and Austin. Same-day appointments are available. Schedule a free virtual consultation at injectco.com/services/p-shot-dallas-fort-worth/ to talk through your situation with a licensed provider before committing to anything.
For oral medications, your primary care provider or a telehealth platform can handle prescriptions. For shockwave therapy, look for men’s health clinics or urology practices with documented protocols and equipment, not just home device rental programs.
For the P-Shot or GlansGirth, choose a clinic with licensed medical staff, physician oversight, and a track record with PRP and filler treatments specifically. Ask how many procedures they have performed, what centrifuge system they use, and who administers the injection. Those answers tell you a lot.
InjectCo’s locations across Texas provide straightforward access for men in the DFW metroplex, Houston, Austin, and surrounding communities. Use the location finder at injectco.com/areas-we-serve/ to find the nearest branch.
Several approaches are gaining traction including the P-Shot, GlansGirth, the P-Long Protocol, and improved shockwave delivery systems. None of these are first-line standards of care yet, but all have clinical data supporting their potential. The newest FDA-approved pharmaceutical for ED is avanafil (Stendra), which has a faster onset than older PDE5 inhibitors.
The P-Shot has a growing clinical evidence base. Multiple meta-analyses published in 2024 found statistically significant improvements in erectile function scores in men who received PRP injections. Larger randomized controlled trials are ongoing. It is best described as clinically promising with an emerging evidence base, not unproven.
GlansGirth is penile girth enhancement using hyaluronic acid filler, offered at InjectCo locations across Texas. It is not a direct ED treatment, but it addresses the confidence and sensitivity factors that contribute to psychogenic ED in many men. For men with a psychological component to their ED, GlansGirth can be a meaningful part of a broader treatment plan.
Venous leak is one of the harder forms of ED to treat with oral medications alone. Options include vacuum erection devices, venous embolization (minimally invasive), and penile implants for severe confirmed cases. A penile Doppler ultrasound is needed to confirm venous leak before pursuing any of these options.
Most are not permanent by nature. Oral medications work only while in your system. Shockwave therapy results typically last one to two years before potential repeat treatment. The P-Shot and GlansGirth show more lasting results in clinical observation, with many patients maintaining benefit at 12 to 18 months. The P-Long Protocol results are expected to be long-lasting. Penile implants are permanent.
Yes, younger men often respond especially well to regenerative and non-pharmaceutical approaches because they are addressing root causes, not just symptoms. If your ED has a vascular or lifestyle component, the P-Shot and shockwave therapy have strong clinical rationale. If there is a significant psychological component, GlansGirth and counseling may be more relevant starting points.
L-citrulline has the most consistent evidence among over-the-counter supplements, particularly for mild ED with a blood flow component. Pycnogenol combined with L-arginine has shown benefit in small trials. Panax ginseng has modest support across several systematic reviews. None of these replace medical treatment for moderate to severe ED.
Ask how many P-Shot procedures the clinic has performed, what centrifuge system they use for PRP preparation, who administers the injection (nurse injector with physician oversight vs. delegation), and whether you will receive a clinical consultation before treatment. At InjectCo, all four answers are covered before any procedure begins.
